Robert S. Kirsner, MD, PhD, FAAD
SESSIONS
DISCLOSURES
35 Pharma – Consultant (1099 relationship)(Honoraria); AbbVie – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); BPGbio – Consultant (1099 relationship)(Honoraria); Hoth Therapeutics – Investigator(Grants/Research Funding); Kenvue – Consultant (1099 relationship)(Honoraria); Kerecis Limited – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria); MediWound – Investigator(Grants/Research Funding); Organogenesis, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Smith & Nephew – Advisory Board(Honoraria); SolasCure – Consultant (1099 relationship)(Honoraria); Tempo therapeutics – Consultant (1099 relationship)(Honoraria); Urgo Group – Advisory Board(Honoraria);